Login / Signup

Trends, Cost and Predictors of Local Hemostatics Use in Major Urological Surgery.

Camilo Arenas-GalloPatrick LewickiMegan PruntyAaron BrantStephen RhodesSpyridon P BasourakosAlec ZhuBashir Al Hussein Al AwamlhJonathan E Shoag
Published in: Urology practice (2023)
The use of hemostatic agents in major urologic surgeries has grown over the past 2 decades. For all procedures, the specific cost of using a hemostatic agent constitutes a small fraction of the total hospitalization cost and does not vary significantly between open and lap/robotic approaches. Some patient, surgeon, and hospital characteristics are highly correlated with their use.
Keyphrases
  • minimally invasive
  • robot assisted
  • coronary artery bypass
  • acute care
  • surgical site infection
  • drug induced